Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Nichren
    Junior Member
    • Jun 2018
    • 2

    #1

    RNA.seq FFPE

    Hi All,

    I'm fairly new to RNA.seq and newer to RNA.seq of FFPE tissues. And thought I'd tap into the knowledge base here.

    We have a number of RNA samples derived from FFPE tissue, they have DV200 scores above 50% and 1ug or so total yield. We are looking to get as much information from them as possible and I was thinking of using the Illumina RNA Exome kit for library prep or another capture method to look at isoform changes.

    Or should I just be looking at ribo-depletion and sequencing deep?
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    You have enough quantity and relatively good quality RNA for a FFPE sample. Ribo-depletion will be good choice as it is open for transcriptome wide discovery and sequencing cost with NovaSeq is also relatively low.

    Comment

    • Nichren
      Junior Member
      • Jun 2018
      • 2

      #3
      Originally posted by nucacidhunter View Post
      You have enough quantity and relatively good quality RNA for a FFPE sample. Ribo-depletion will be good choice as it is open for transcriptome wide discovery and sequencing cost with NovaSeq is also relatively low.
      Thinking TruSeq Stranded Total RNA, to get as much information as possible, and yes they are surprisingly good samples.

      Any experience with this library prep kit and FFPE RNA, nucacidhunter?

      Comment

      • nucacidhunter
        Jafar Jabbari
        • Jan 2013
        • 1250

        #4
        In theory TruSeq can be used but I have not seen any convincing evidence from Illumina using this kit for FFPE RNA-Seq. Instead, they have focused more on targeted approaches such as RNA exome (formerly RNA access). This paper also indicates poor performance:
        The molecular classification of glioblastoma (GBM) based on gene expression might better explain outcome and response to treatment than clinical factors. Whole transcriptome sequencing using next-generation sequencing platforms is rapidly becoming accepted as a tool for measuring gene expression for both research and clinical use. Fresh frozen (FF) tissue specimens of GBM are difficult to obtain since tumor tissue obtained at surgery is often scarce and necrotic and diagnosis is prioritized over freezing. After diagnosis, leftover tissue is usually stored as formalin-fixed paraffin-embedded (FFPE) tissue. However, RNA from FFPE tissues is usually degraded, which could hamper gene expression analysis. We compared RNA-Seq data obtained from matched pairs of FF and FFPE GBM specimens. Only three FFPE out of eleven FFPE-FF matched samples yielded informative results. Several quality-control measurements showed that RNA from FFPE samples was highly degraded but maintained transcriptomic similarities to RNA from FF samples. Certain issues regarding mutation analysis and subtype prediction were detected. Nevertheless, our results suggest that RNA-Seq of FFPE GBM specimens provides reliable gene expression data that can be used in molecular studies of GBM if the RNA is sufficiently preserved.


        Other supplies such as NEB (NEBNext Ultra II Directional RNA Library Pre) or Clontech (SMARTer Stranded Total RNA-Seq Kit – Pico Input Mammalian v2) have published tech notes using their kits and worth considering.

        Comment

        • Geneus
          Member
          • Dec 2010
          • 60

          #5
          Quick question for the OP...what method did you use for your extraction from FFPE and how many curls/slides did you use to obtain 1ug of RNA? If these were slides did you perform any macro-dissection? The devil's in the details.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          33 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-13-2026, 09:56 AM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-09-2026, 11:14 AM
          0 responses
          28 views
          0 reactions
          Last Post SEQadmin2  
          Working...